DarioHealth Corp.
DRIO
$0.7831
-$0.0369-4.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.87% | -2.09% | -28.10% | -28.57% | -26.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.87% | -2.09% | -28.10% | -28.57% | -26.41% |
| Cost of Revenue | -12.39% | -13.81% | -30.29% | -29.96% | -26.83% |
| Gross Profit | 76.44% | 7.27% | -26.21% | -27.18% | -26.00% |
| SG&A Expenses | 10.30% | 19.45% | 16.28% | 4.00% | -10.72% |
| Depreciation & Amortization | 14.64% | 7.50% | 2.24% | -0.84% | 0.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.00% | 11.65% | 8.07% | 0.68% | -9.53% |
| Operating Income | -1.70% | -18.00% | -27.33% | -15.30% | 1.31% |
| Income Before Tax | 24.87% | 14.57% | 8.54% | 5.74% | 4.54% |
| Income Tax Expenses | -2,993.75% | -64,866.67% | -64,433.33% | -48,350.00% | 1,500.00% |
| Earnings from Continuing Operations | 28.07% | 17.93% | 11.89% | 9.01% | 4.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.07% | 17.93% | 11.89% | 9.01% | 4.45% |
| EBIT | -1.70% | -18.00% | -27.33% | -15.30% | 1.31% |
| EBITDA | 2.92% | -17.15% | -28.49% | -16.42% | 1.95% |
| EPS Basic | 66.22% | 53.94% | 45.72% | 28.43% | 26.78% |
| Normalized Basic EPS | 50.94% | 32.87% | 26.11% | 22.51% | 24.96% |
| EPS Diluted | 65.98% | 53.78% | 45.87% | 28.59% | 26.94% |
| Normalized Diluted EPS | 50.94% | 32.87% | 26.11% | 22.51% | 24.96% |
| Average Basic Shares Outstanding | 70.58% | 29.97% | 26.14% | 21.71% | 24.79% |
| Average Diluted Shares Outstanding | 70.58% | 29.97% | 26.14% | 21.71% | 24.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |